SCHEMBL9429798

SCHEMBL9429798

CC=CC(=O)N(c1ccc(-c2ccc(C)cc2)s1)C1CCNC1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CDK2AP1 O14519 1/20 0.35
CHEK1 O14757 1/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
SLC6A4 P31645 11/20 0.33
SLC6A2 P23975 10/20 0.33
SLC6A3 Q01959 8/20 0.33
KCNH2 Q12809 3/20 0.33
TRPM8 Q7Z2W7 2/20 0.33
MMP13 P45452 1/20 0.33
MCHR1 Q99705 1/20 0.33
RAB9A P51151 1/20 0.32
CYP2D6 P10635 3/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429795 0.91 SLC6A4 (0.34) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL9429984 0.91 SLC6A4 (0.39) CDK2AP1CHEK1SLC6A4SLC6A2SLC6A3
SCHEMBL9428841 0.90 HSD17B1 (0.38) HSD17B1HSD17B2SLC6A4SLC6A2SLC6A3
SCHEMBL9429749 0.89 EP300 (0.35) SLC6A4SLC6A2SLC6A3KCNH2MMP13
SCHEMBL9428532 0.89 MCHR1 (0.40) CDK2AP1CHEK1SLC6A4SLC6A2SLC6A3
SCHEMBL9429644 0.89 APP (0.37) CHEK1HSD17B1HSD17B2TRPM8MMP13
SCHEMBL9428671 0.88 MMP13 (0.33) SLC6A4SLC6A2SLC6A3KCNH2MMP13
SCHEMBL9429264 0.87 PRF1 (0.39) SLC6A4SLC6A2SLC6A3KCNH2RAB9A
SCHEMBL9429149 0.86 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL9428834 0.85 SLC6A4 (0.39) SLC6A4SLC6A2SLC6A3KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed